25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2.
Nutrients
; 12(5)2020 May 09.
Article
Dans Anglais
| MEDLINE | ID: covidwho-1725875
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), with a clinical outcome ranging from mild to severe, including death. To date, it is unclear why some patients develop severe symptoms. Many authors have suggested the involvement of vitamin D in reducing the risk of infections; thus, we retrospectively investigated the 25-hydroxyvitamin D (25(OH)D) concentrations in plasma obtained from a cohort of patients from Switzerland. In this cohort, significantly lower 25(OH)D levels (p = 0.004) were found in PCR-positive for SARS-CoV-2 (median value 11.1 ng/mL) patients compared with negative patients (24.6 ng/mL); this was also confirmed by stratifying patients according to age >70 years. On the basis of this preliminary observation, vitamin D supplementation might be a useful measure to reduce the risk of infection. Randomized controlled trials and large population studies should be conducted to evaluate these recommendations and to confirm our preliminary observation.
Mots clés
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Sujet Principal:
Pneumopathie virale
/
Vitamine D
/
Infections à coronavirus
Type d'étude:
Étude de cohorte
/
Étude diagnostique
/
Études expérimentales
/
Étude observationnelle
/
Étude pronostique
/
Essai contrôlé randomisé
Les sujets:
Médecine traditionnelle
Limites du sujet:
Adulte très âgé
/
Femelle
/
Humains
/
Mâle
/
Adulte d'âge moyen
Pays comme sujet:
Europe
langue:
Anglais
Année:
2020
Type de document:
Article
Pays d'affiliation:
Nu12051359
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS